Target Name: MIR5701-2
NCBI ID: G100847005
Review Report on MIR5701-2 Target / Biomarker Content of Review Report on MIR5701-2 Target / Biomarker
MIR5701-2
Other Name(s): microRNA 5701-2 | MicroRNA 5701-2 | hsa-miR-5701 | hsa-mir-5701-2

MIR5701-2: A Drug Target / Disease Biomarker

MIR5701-2 is a protein that is expressed in various tissues of the body, including the lungs, heart, liver, and kidneys. It is a member of the integrin alpha-2 (IAAG) family, which is a group of transmembrane proteins that are involved in cell-cell and cell-extracellular matrix (ECM) interactions.

One of the unique features of MIR5701-2 is its ability to interact with ECM components such as cadherins and non-cadherin proteins. This interaction allows MIR5701-2 to play a role in the regulation of cell-cell adhesion and ECM-protein interactions, which are important for various physiological processes such as tissue repair, regeneration, and cancer progression.

In addition to its role in cell-cell and ECM interactions, MIR5701-2 has also been shown to play a role in the regulation of cellular processes such as cell cycle progression, apoptosis (programmed cell death), and angiogenesis (the formation of new blood vessels).

MIR5701-2 has also been shown to be involved in the regulation of inflammation and immune responses. It has been shown to play a role in the regulation of T cell development and function, as well as the regulation of inflammation in the body.

Due to its unique ability to interact with ECM components and its role in various cellular processes, MIR5701-2 has been identified as a potential drug target. Researchers have been studying the effects of various small molecules and biochemicals on MIR5701-2, in an effort to determine its potential as a drug.

One of the most promising compounds that has been shown to interact with MIR5701-2 is called N-acetyl-L-tryptophan (NALP). NALP is a amino acid that has been shown to interact with MIR5701-2 and can inhibit its activity.

NALP inhibition of MIR5701-2 has been shown to have a variety of potential therapeutic effects. For example, it has been shown to have anti-inflammatory effects, as well as the ability to protect against oxidative stress and cellular stress.

In addition to its potential therapeutic effects, NALP inhibition of MIR5701-2 also has the potential to be a useful biomarker. By measuring the levels of MIR5701-2 in cells, researchers can monitor the effectiveness of NALP inhibitors and other drugs for their ability to interact with MIR5701-2 and to assess their potential therapeutic effects.

Overall, MIR5701-2 is a protein that has a unique role in various cellular processes and has been identified as a potential drug target. The interaction between MIR5701-2 and ECM components, as well as its role in cell-cell and ECM interactions, makes it an attractive target for the development of new therapeutic compounds. Furthermore, the potential role of MIR5701-2 as a biomarker for the effectiveness of NALP inhibitors adds to its potential utility as a drug.

Protein Name: MicroRNA 5701-2

The "MIR5701-2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR5701-2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR5701-3 | MIR5702 | MIR5703 | MIR5704 | MIR5705 | MIR5706 | MIR5707 | MIR5708 | MIR570HG | MIR571 | MIR572 | MIR573 | MIR5739 | MIR574 | MIR575 | MIR576 | MIR577 | MIR578 | MIR5787 | MIR579 | MIR580 | MIR581 | MIR582 | MIR583 | MIR584 | MIR585 | MIR586 | MIR587 | MIR588 | MIR589 | MIR590 | MIR591 | MIR592 | MIR593 | MIR595 | MIR596 | MIR597 | MIR598 | MIR599 | MIR600 | MIR600HG | MIR601 | MIR602 | MIR603 | MIR604 | MIR605 | MIR606 | MIR6068 | MIR6069 | MIR607 | MIR6070 | MIR6071 | MIR6072 | MIR6073 | MIR6074 | MIR6075 | MIR6076 | MIR6077 | MIR6078 | MIR608 | MIR6080 | MIR6081 | MIR6082 | MIR6083 | MIR6084 | MIR6085 | MIR6086 | MIR6088 | MIR6089 | MIR609 | MIR6090 | MIR610 | MIR611 | MIR612 | MIR6124 | MIR6125 | MIR6126 | MIR6127 | MIR6128 | MIR6129 | MIR613 | MIR6130 | MIR6131 | MIR6132 | MIR6133 | MIR6134 | MIR614 | MIR615 | MIR616 | MIR6165 | MIR617 | MIR618 | MIR619 | MIR620 | MIR621 | MIR622 | MIR623 | MIR624 | MIR625 | MIR626